Non-albuminuric chronic kidney disease in diabetes: A different approach?

by Rikke Borg, Frederik Persson
Published 2022-01-01

The Growing Challenge of Chronic Kidney Disease: An Overview of Current Knowledge

by Rikke Borg, Nicholas Carlson, Jens Søndergaard, Frederik Persson
Published 2023-01-01

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

by Frederik Persson, Morten Lindhardt, Peter Rossing, Hans-Henrik Parving
Published 2016-07-01

Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data

by Hanan Amadid, Kim Katrine Bjerring Clemmensen, Dorte Vistisen, Frederik Persson, Marit Eika Jørgensen
Published 2022-11-01

Is Time-Restricted Eating Safe in the Treatment of Type 2 Diabetes?—A Review of Intervention Studies

by Sarah Uldal, Kim Katrine Bjerring Clemmensen, Frederik Persson, Kristine Færch, Jonas Salling Quist
Published 2022-05-01

Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death

by Rikke Borg, Margit Kriegbaum, Mia Klinten Grand, Bent Lind, Christen Lykkegaard Andersen, Frederik Persson
Published 2023-06-01

Impact of glycaemic control on the effect of direct renin inhibition in the AVOID study

by Frederik Persson, Julia B Lewis, Edmund J Lewis, Peter Rossing, Norman K Hollenberg, Hans-Henrik Parving
Published 2012-06-01

Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy

by Frederik Persson, Julia B Lewis, Edmund J Lewis, Peter Rossing, Norman K Hollenberg, Parving Hans-Henrik
Published 2012-03-01

Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes – A comparative study of two ma...

by Kasper Broedbaek, Rasmus Køster-Rasmussen, Volkert Siersma, Frederik Persson, Henrik E. Poulsen, Niels de Fine Olivarius
Published 2017-10-01

Measurement of bioactive renin concentration and renin activity in the presence of exogenous renin substrate: effect of the oral direct renin inhibitor aliskiren

by Erik Frandsen, Frans Boomsma, Frederik Persson, Ching-Ming Yeh, Hans-Armin Dieterich, William P Dole, Margaret F Prescott
Published 2008-03-01

Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.

by Elisabeth Buur Stougaard, Signe Abitz Winther, Hanan Amadid, Marie Frimodt-Møller, Frederik Persson, Tine Willum Hansen, Peter Rossing
Published 2021-01-01

Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions.

by Mie Klessen Eickhoff, Signe Abitz Winther, Tine Willum Hansen, Lars Jorge Diaz, Frederik Persson, Peter Rossing, Marie Frimodt-Møller
Published 2020-01-01

Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease

by Stine E Nielsen, Katrine J Schjoedt, Kasper Rossing, Frederik Persson, Casper G Schalkwijk, Coen DA Stehouwer, Hans-Henrik Parving, Peter Rossing
Published 2013-06-01

Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

by Viktor Rotbain Curovic, Morten B. Houlind, Tine W. Hansen, Jesper Eugen-Olsen, Jens Christian Laursen, Mie K. Eickhoff, Frederik Persson, Peter Rossing, Peter Rossing
Published 2022-04-01

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and mi...

by Emilie H. Zobel, Bernt Johan von Scholten, Henrik Reinhard, Frederik Persson, Tom Teerlink, Tine W. Hansen, Hans-Henrik Parving, Peter K. Jacobsen, Peter Rossing
Published 2017-07-01

Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy...

by Carina Kirstine Klarskov, Helga Holm Schultz, Frederik Persson, Tomas Møller Christensen, Thomas Peter Almdal, Ole Snorgaard, Katrine Bagge Hansen, Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen
Published 2020-06-01

Faecal biomarkers in type 1 diabetes with and without diabetic nephropathy

by Signe Abitz Winther, Miia Maininki Mannerla, Marie Frimodt-Møller, Frederik Persson, Tine Willum Hansen, Markku Lehto, Sohvi Hörkkö, Michael Blaut, Carol Forsblom, Per-Henrik Groop, Peter Rossing
Published 2021-07-01

Diabetes treatment for persons with severe mental illness: A registry-based cohort study to explore medication treatment differences for persons with type 2 diabetes with and witho...

by Catrine Bakkedal, Frederik Persson, Margit Kriegbaum, John Sahl Andersen, Mia Klinten Grant, Grimur Høgnason Mohr, Bent Struer Lind, Christen Lykkegaard Andersen, Mikkel Bring Christensen, Volkert Siersma, Maarten Pieter Rozing
Published 2023-01-01

Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)

by Torben Hansen, Rikke Borg, Ditte Hansen, Peter Rossing, Marie Møller, Frederik Persson, Iain Bressendorff, Lisbeth N Fink, Eva Gravesen, Karina Haar Jensen, Dorrit Krustrup, Frederikke E Sembach, Anne C B Thuesen
Published 2023-06-01

Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)

by Hans-Henrik Parving, Barry M Brenner, John JV McMurray, Dick de Zeeuw, Steven M Haffner, Scott D Solomon, Nish Chaturvedi, Frederik Persson, Maria Nicolaides, Alexia Richard, Zhihua Xiang, Juergen Armbrecht, Marc A Pfeffer
Published 2012-09-01